Cita APA

Kang, M. H., Reynolds, C. P., Kolb, E. A., Gorlick, R., Carol, H., Lock, R., . . . Smith, M. A. (2016). Initial Testing (Stage 1) of MK-8242, a Novel MDM2 Inhibitor, by the Pediatric Preclinical Testing Program. Pediatr Blood Cancer.

Citación estilo Chicago

Kang, Min H., et al. "Initial Testing (Stage 1) of MK-8242, a Novel MDM2 Inhibitor, By the Pediatric Preclinical Testing Program." Pediatr Blood Cancer 2016.

Cita MLA

Kang, Min H., et al. "Initial Testing (Stage 1) of MK-8242, a Novel MDM2 Inhibitor, By the Pediatric Preclinical Testing Program." Pediatr Blood Cancer 2016.